| Bristol-Myers Squibb Company (BMY) | |||
|---|---|---|---|
| 52.12 -1.52 (-2.83%) | 12-14 16:02 | ||
| Open: | 53.21 | Pre. Close: | 53.64 |
| High: | 53.26 | Low: | 51.93 |
| Volume: | 10,708,011 | Market Cap: | 85070M |
| Price Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 53.317 - 53.623 | 53.623 - 53.899 |
| Low: | 51.24 - 51.572 | 51.572 - 51.871 |
| Close: | 51.654 - 52.184 | 52.184 - 52.663 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 61.81 One year: 64.02 |
| Support: | Support1: 49.86 Support2: 41.48 |
| Resistance: | Resistance1: 52.92 Resistance2: 54.81 |
| Pivot: | 52.66 |
| Moving Averages: | MA(5): 52.84 MA(20): 52.87 MA(100): 57.16 MA(250): 58.21 |
| MACD: | MACD(12,26): -0.21 Signal(12,26,9): -0.34  |
| %K %D: | %K(14,3): 73.12 %D(3): 71.54 |
| RSI: | RSI(14): 45.06 |
| 52-Week: | High: 70.05 Low: 46.94 Change(%): -16.5 |
| Average Vol(K): | 3-Month: 879449 10-Days: 910489 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.BMY has closed above bottom band by 31.0%. Bollinger Bands are 42.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMY's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend. |
| Stock chart |
|---|
 |
| Stock News |
|---|
|
2018-12-15T05:31:46-05:00 Nicholas Ward's Dividend Growth Portfolio: November Update |
| Financial Analysis | |
|---|---|
| Growth |  |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability | |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency |  |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Sector: Healthcare | |
| Industry: Drug Manufacturers - Major | |
| Shares Out. (M) | 1632.20 |
| Shares Float (M) | 1625.96 |
| % Held by Insiders | 0.40 |
| % Held by Institutions | 109.50 |
| Shares Short (K) | 11924 |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | 3.720 |
| EPS Est. Current Year | 3.000 |
| EPS Est. Next Year | 3.230 |
| EPS Est. Next Quarter | 0.790 |
| Forward EPS | 3.720 |
| Book Value (p.s.) | 6.370 |
| PEG Ratio | 1.25 |
| Profit Margin | 6.98 |
| Operating Margin | 27.26 |
| Return on Assets (ttm) | 4.2 |
| Return on Equity (ttm) | 10.1 |
| Qtrly Rev. Growth | 8.3 |
| Gross Profit (p.s.) | 2.313 |
| Sales Per Share | |
| EBITDA (p.s.) | 0.580 |
| Qtrly Earnings Growth | 125.00 |
| Operating Cash Flow (M) | 4630.00 |
| Levered Free Cash Flow (M) | 3260.00 |
| Stock Valuation | |
|---|---|
| P/E | 14.01 |
| P/E Growth Ratio | -0.03 |
| P/BV | 8.18 |
| P/S | 6298880512.00 |
| P/CF | 18.38 |
| Dividend Yield | 0.06 |
| Dividends & Splits | |
|---|---|
| Dividend | 3.090 |
| Dividend Pay Date | 2018-11-01 |
| Ex-Dividend Date | 2018-10-04 |
| Forward Dividend | 1.600 |
| Last Split Date | |
| Last Split Ratio | -1e+010 |
